Microsoft (MSFT) Stock Forecast & Price Target

$383.52 -5.18 (-1.33%)

Closing price 04:00 PM Eastern

Extended Trading

$383.55 +0.03 (+0.01%)

As of 04:40 PM Eastern

Microsoft - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 29 Analyst Ratings

Sell
0

Hold
2

Buy
27

Based on 29 Wall Street analysts who have issued ratings for Microsoft in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 29 analysts, 2 have given a hold rating, and 27 have given a buy rating for MSFT.

Consensus Price Target

$510.43
33.09% Upside

According to the 29 analysts' twelve-month price targets for Microsoft, the average price target is $510.43. The highest price target for MSFT is $600.00, while the lowest price target for MSFT is $450.00. The average price target represents a forecasted upside of 33.09% from the current price of $383.52.

Get the Latest News and Ratings for MSFT and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Microsoft and its competitors.

MSFT Analyst Ratings Over Time

Type	Current Forecast 3/18/24 to 3/18/25	1 Month Ago 2/17/24 to 2/16/25	3 Months Ago 12/19/23 to 12/18/24	1 Year Ago 3/19/23 to 3/18/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	27 Buy rating(s)	26 Buy rating(s)	26 Buy rating(s)	36 Buy rating(s)
Hold	2 Hold rating(s)	3 Hold rating(s)	2 Hold rating(s)	3 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$510.43	$510.96	$508.46	$415.00
Forecasted Upside	33.09% Upside	25.10% Upside	16.25% Upside	-0.56% Downside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

Remove Ads

MSFT Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

MSFT Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Microsoft Stock vs. The Competition

Type	Microsoft	Computer and Technology Companies	S&P 500
Consensus Rating Score	2.93	2.68	2.54
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	31.32% Upside	149.92% Upside	18.07% Upside
News Sentiment Rating	Positive News See Recent MSFT News	Positive News	Positive News

Remove Ads

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
3/13/2025	DA Davidson 2 of 5 stars	G. Luria Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$425.00 ➝ $450.00	+17.41%
3/7/2025	Stifel Nicolaus 4 of 5 stars	Brad Reback Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$515.00 ➝ $475.00	+22.67%
1/30/2025	UBS Group 4 of 5 stars	Karl Keirstead Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$525.00 ➝ $510.00	+22.89%
1/30/2025	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Rishi Jaluria Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$500.00 ➝ $500.00	+20.41%
1/30/2025	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Gregg Moskowitz Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform ➝ Outperform	$510.00 ➝ $500.00	+13.04%
1/30/2025	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Keith Weiss Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$540.00 ➝ $530.00	+19.82%
1/29/2025	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Blakey Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$509.00 ➝ $509.00	+15.45%
1/27/2025	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brent Bracelin Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$520.00 ➝ $520.00	+19.66%
1/24/2025	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	John Difucci Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral
12/23/2024	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$500.00 ➝ $550.00	+25.97%
Get the Latest News and Ratings for MSFT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Microsoft and its competitors with MarketBeat's FREE daily newsletter.
11/19/2024	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Ives Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform	$550.00	+31.65%
10/31/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$470.00 ➝ $465.00	+13.84%
10/31/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$495.00 ➝ $475.00	+15.76%
10/31/2024	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform	$500.00 ➝ $495.00	+14.44%
10/28/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$600.00 ➝ $600.00	+40.27%
10/25/2024	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$501.00 ➝ $500.00	+17.72%
10/23/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$500.00 ➝ $497.00	+15.50%
10/18/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy
10/18/2024	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$490.00 ➝ $505.00	+21.18%
10/10/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$515.00 ➝ $500.00	+19.77%
10/8/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Market Perform
7/17/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$480.00 ➝ $510.00	+13.45%
7/9/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$475.00 ➝ $526.00	+14.01%
6/13/2024	Tigress Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$475.00 ➝ $550.00	+24.52%
6/10/2024	New Street Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	P. Ferragu Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$570.00	+34.48%
5/17/2024	Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$460.00 ➝ $475.00	+13.24%
4/26/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$450.00 ➝ $480.00	+17.41%
4/26/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$475.00 ➝ $485.00	+21.54%
4/1/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$465.00 ➝ $550.00	+29.59%
1/31/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$421.00 ➝ $475.00	+16.25%
1/18/2024	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Outperform	$471.00	+20.93%
12/5/2023	China Renaissance Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$466.00	+26.24%
10/26/2023	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$370.00 ➝ $375.00	+13.01%
10/26/2023	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$347.00 ➝ $413.00	+21.23%
8/11/2023	Redburn Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$450.00 ➝ $440.00	+36.25%
8/9/2023	Fundamental Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Set Target	Hold	$298.10	-8.06%
5/31/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$350.00 ➝ $420.00	+26.81%
5/30/2023	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$340.00 ➝ $380.00	+14.15%
4/26/2023	888 Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Maintains
4/26/2023	Atlantic Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight	$290.00 ➝ $330.00	+11.98%
Lying in hospital… staring at the light (Ad) "Please don’t die on me," the nurse begged as Porter Stansberry lay in a hospital bed, his heart stopped from years of pushing himself too hard. At his lowest point, he realized that everything had gone wrong, and he was forced to rebuild—not just his health, but his entire life and fortune. After clawing his way out of that abyss, Porter discovered a life-changing investment strategy, one that allowed him to rebuild his wealth far faster and with less risk than he ever imagined. This approach helped him earn enormous returns outside of the volatile stock market, and now he’s sharing it with you. While most won’t believe it’s possible, Porter is asking you to open your mind and consider a new way of investing—one that could transform your financial future, just as it did for him. [Click here] to learn more about this powerful strategy and discover your own financial "Second Life
4/26/2023	Moffett Nathanson Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Market Perform	$263.00 ➝ $306.00	+3.83%
4/26/2023	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform	$330.00 ➝ $350.00	+27.08%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 04:41 PM ET.

Should I Buy Microsoft Stock? MSFT Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, March 12, 2025. Please send any questions or comments about these Microsoft pros and cons to contact@marketbeat.com.

Microsoft
Bull Case

Here are some ways that investors could benefit from investing in Microsoft:

Microsoft has a strong market capitalization of $2.85 trillion, indicating its significant presence and stability in the tech industry, which can provide a sense of security for investors.
The company reported a robust earnings per share (EPS) of $3.23, exceeding analysts' expectations, showcasing its strong profitability and operational efficiency.
With a current stock price around $414.68, which is near its fifty-day moving average, it may present a favorable entry point for investors looking to capitalize on potential growth.
Microsoft's diverse product offerings, including the latest versions of Microsoft 365 and Azure cloud services, position it well for continued revenue growth in the expanding cloud computing market.
The company has a solid dividend yield of 0.87% with a payout ratio of 26.73%, indicating a commitment to returning value to shareholders while maintaining sufficient reinvestment in the business.

Microsoft
Bear Case

Investors should be bearish about investing in Microsoft for these reasons:

Despite its strong performance, Microsoft has a relatively high P/E ratio of 30.89, which may suggest that the stock is overvalued compared to its earnings, potentially limiting future price appreciation.
The company has faced recent downgrades from analysts, with some lowering their target prices, indicating a lack of confidence in short-term growth prospects.
Microsoft's beta of 0.92 suggests that its stock is less volatile than the market, which may limit potential gains during bullish market conditions.
With a debt-to-equity ratio of 0.13, while low, it indicates that the company is not leveraging debt for growth, which could be a disadvantage in a competitive market where aggressive investment is necessary.
Recent market trends show increasing competition in cloud services, which could impact Microsoft's market share and profitability in the long run.

MSFT Forecast - Frequently Asked Questions

: According to the research reports of 29 Wall Street equities research analysts, the average twelve-month stock price forecast for Microsoft is $510.43, with a high forecast of $600.00 and a low forecast of $450.00.
: 29 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Microsoft in the last twelve months. There are currently 2 hold ratings and 27 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" MSFT shares.
: According to analysts, Microsoft's stock has a predicted upside of 33.09% based on their 12-month stock forecasts.
: Over the previous 90 days, Microsoft's stock had 2 upgrades by analysts.
: Microsoft has been rated by research analysts at Cantor Fitzgerald, DA Davidson, Guggenheim, Loop Capital, Mizuho, Morgan Stanley, Piper Sandler, Royal Bank of Canada, Stifel Nicolaus, and UBS Group in the past 90 days.
: Analysts like Microsoft more than other "computer and technology" companies. The consensus rating score for Microsoft is 2.93 while the average consensus rating score for "computer and technology" companies is 2.69. Learn more on how MSFT compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NASDAQ:MSFT) was last updated on 3/18/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Microsoft (MSFT) Stock Forecast & Price Target